Best Brand-Name GLP-1 via NovoCare Pharmacy: All 4 Options, Priced by Dose

---

The best brand-name GLP-1 via NovoCare Pharmacy depends first on the FDA-approved use. NovoCare sells four brand-name GLP-1 product lanes, and they're all semaglutide: Wegovy pen, Wegovy pill, Ozempic pen, and Ozempic pill. Which drug you get isn't really a choice — your diagnosis and the FDA-approved use narrow it, NovoCare's own rules enforce that, and your prescriber makes the clinical decision. The preference you can bring to that visit is pill or pen. For an eligible new patient who gets both current intro offers, the Wegovy pill runs about $949 less in the first year. Without either intro offer, it runs about $1,199 less.

That answer changes if any of these fit you:

• You have type 2 diabetes. Then this is an Ozempic question, and the numbers are different.
• You have commercial insurance that covers the drug. An eligible $25 savings-offer copay beats every cash price here — but you can't get that price through NovoCare's home delivery. We'll show you why.
• You're on Medicare. There's a separate $50-per-fill federal program for eligible Part D members through December 31, 2027.
• You can't take a pill on an empty stomach every morning. The pen is once a week and doesn't care what you ate.

Here's the part almost nobody has caught: the same headline self-pay prices are offered under two different rulebooks that don't agree with each other. Same drug. Same dollar amount. Two sets of terms, different definitions of "new patient," and different deadlines. Pick the wrong door and you can lose an intro price early — or miss a route that works better with insurance. We read both. Section 6 has the whole thing.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

---

Best for you / not for you

NovoCare Pharmacy is a good fit if you:

• Want the real brand-name drug from the company that makes it, not a compounded version
• Already have a doctor who will write the prescription
• Are paying cash and want Novo Nordisk's published self-pay medicine price without a separate care membership
• Want it shipped to your house for free

Look somewhere else if you:

• Don't have a prescriber yet — NovoCare can't be one, and that's the whole snag (jump to Section 9)
• Want Zepbound or Mounjaro — different company, different pharmacy → see our LillyDirect guide
• Need a cash purchase to run through insurance or count toward your deductible — NovoCare Pharmacy is cash-only, and its terms say not to submit the purchase for reimbursement
• Want a compounded medicine — NovoCare doesn't sell those, and we don't mix the two on this page
• Want a coach, a care team, or a prescriber who can assess side effects and change the plan. This is a pharmacy channel, not a clinical care program.

---

All four, side by side

Prices are NovoCare's cash/self-pay program prices, verified August 15, 2026 against Novo Nordisk's own published terms. First-year totals are our calculation — we show the math and assumptions in Section 5. Eligibility rules apply and Novo Nordisk can change or end these programs.

Provider-stated vs. verified

NovoCare Picker: five quick questions

---

1. What is the best brand-name GLP-1 via NovoCare Pharmacy?

For weight loss, the Wegovy pill is the lowest-cost option in our NovoCare Pharmacy first-year model — about $3,288 if you qualify for the limited $149 price on the 4 mg bottle, or $3,338 at the standard $199 price. The Wegovy pen costs about $4,237 with its two-fill intro offer or $4,537 without it. Ozempic is also sold here, but NovoCare's terms only allow it to be purchased for a use on its own FDA label, and weight loss is not one of them.

Let's be straight about what "best" can and can't mean here.

We're not going to tell you which medicine is right for your body. Nobody writing a web page can do that honestly. Your doctor picks the drug, the form, and the dose based on your health history, and that's not a decision a price table should make.

But there's a version of "best" we can answer, and it's probably the one you actually came for:

Of the four things NovoCare sells, which costs less, and how do I get it without messing this up?

That we can answer down to the dollar.

Here's the shape of it. Your diagnosis and the approved use narrow the drug — and your prescriber makes the clinical decision. What you can bring to that conversation is the form. Pill or shot. For an eligible new patient who gets both current intro offers, that choice is worth about $949 in the first year. Without either intro offer, the gap is about $1,199.

---

2. What does NovoCare Pharmacy actually sell?

NovoCare Pharmacy carries four product lanes across 16 package-and-strength entries: Wegovy tablets, Wegovy injection including Wegovy HD, Ozempic tablets, and Ozempic injection. All of them contain semaglutide and all are made by Novo Nordisk. It does not sell Zepbound, Mounjaro, Foundayo, Saxenda, Rybelsus, or any compounded medicine through this program.

This is worth being blunt about: NovoCare sells more than Wegovy.

Novo's own pharmacy page says all doses of the Wegovy pill, Wegovy pen, Ozempic pill, and Ozempic pen are available. And the fine print in NovoCare's terms lists every item by its NDC number — the code tied to a specific drug, dose, package, and labeler. We show the 10-digit package-label format below. NovoCare's terms often show the same NDC with an added leading zero for 11-digit billing. Here's the complete list.

The complete NovoCare Pharmacy list, August 2026

Sources: NovoCare Pharmacy Terms and Conditions and the current FDA-approved prescribing information, read August 15, 2026.

\* One source conflict we found: NovoCare's terms currently print 00169-1704-15 for the Ozempic 4 mg, 30-tablet bottle. The FDA-approved Ozempic Tablets prescribing information lists 0169-1704-30. We use the label's package NDC above and flag the mismatch instead of silently guessing. A prescriber or pharmacist should confirm the live product listing when sending the prescription.

Why bother printing NDC numbers? Because when a prescription gets sent to the wrong item, that's the number that fixes it. If your doctor's system shows several versions of “Ozempic,” this table tells you which package the price belongs to.

What's not here: tirzepatide in any form. That's Eli Lilly's molecule — Zepbound and Mounjaro — and it lives at a different pharmacy entirely. If that's what you came for, our LillyDirect guide is the right page and this one will waste your time.

---

3. Wegovy or Ozempic — which one is even yours?

NovoCare Pharmacy's terms allow the program only when the medicine is prescribed for an FDA-approved use on that exact product's label. For adult weight treatment, the NovoCare choices are Wegovy tablets or Wegovy injection. Wegovy HD 7.2 mg is only a later adult-weight option after at least four weeks at 2.4 mg, when the prescriber decides more weight reduction is clinically indicated. Ozempic is not FDA-approved for weight loss. Its tablet and injection labels cover type 2 diabetes, but the two Ozempic forms do not have identical outcome indications.

People get confused here, and it's not their fault. Wegovy and Ozempic contain the same active ingredient. Same company. Same molecule. So why two names and two prices?

Because the FDA approves a drug for a use, not just a molecule. Novo ran different studies, at different doses, for different problems, and got separate labels. Separate rulebooks.

And NovoCare wrote that into its purchase agreement: the prescription must be for an “FDA-approved indication within that product's labeling.”

So the four-way choice collapses fast:

This is not us being cautious. It's the actual purchase term. If you were hoping to get Ozempic through NovoCare because you saw a cheaper number next to it, that door is closed by the program itself.

Your diagnosis still does not choose the exact form for you. Your prescriber has to match the indication, age, health history, dosing needs, and label to the product.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

---

4. What does each one cost at every dose?

Wegovy tablets cost $149 at 1.5 mg, $199 at the standard 4 mg price, and $299 at 9 mg and 25 mg. Eligible new tablet patients can get one 4 mg fill for $149 under a limited offer with an August 31, 2026 prescription deadline. The Wegovy pen costs $199 for the first two eligible 28-day fills, then $349 through 2.4 mg; Wegovy HD 7.2 mg is $399. Ozempic tablets are $149, $199, and $299 by dose. The Ozempic pen is $199 for two eligible intro fills, then $349 through 1 mg and $499 at 2 mg.

“Starting at $149” is true. It's also the least useful sentence in this entire market, because almost nobody stays at the starting dose.

Here's what you'll actually pay as you move up on the usual label schedule. Your prescriber may hold a dose longer, stop, or change the plan.

Wegovy tablets (daily pill, weight)

The limited 4 mg price is not the permanent standard price. To use the NovoCare Pharmacy version of that offer, the prescription must be written and received by August 31, 2026, and the eligible bottle must ship by September 30, 2026. Without it, the usual price path is $149 in month one, $199 in month two, and $299 in month three.

Notice where the biggest jump lands: month three. Your price goes from $199 to $299 on the standard path, or from $149 to $299 if the limited offer covered month two. That's completely predictable if someone tells you in advance. Now someone has.

Wegovy pen (weekly shot, weight)

The first two $199 prices are limited to eligible new Wegovy injection patients and one 28-day fill at 0.25 mg plus one at 0.5 mg. The pen does something the pill doesn't: the standard price stays $349 from 0.25 mg through 2.4 mg. Flat. That gives you price predictability if your prescriber holds you at a lower dose, because the medicine price does not change across those five strengths.

Wegovy HD is not a routine starting step. The label says a patient first has to tolerate 2.4 mg for at least four weeks, and the prescriber must decide that more weight reduction is clinically indicated.

Ozempic tablets (daily pill, type 2 diabetes)

Ozempic pen (weekly shot, type 2 diabetes)

That last row deserves a flag. Going from the 1 mg pen to the 2 mg pen costs an extra $150 per box. In our first-year model, moving to 2 mg after the usual first three dose steps adds $1,500 because ten boxes are priced at the top dose. A full steady year at 2 mg costs $1,950 more than a full 13-box year at 1 mg. Worth a conversation with your doctor about whether the higher dose is needed — not because a cheaper dose is automatically better, but because the price change is real.

One detail behind our math: NovoCare prices the injection offers in 28-day fills. The Ozempic starter pen can physically contain more than four starter doses under the label schedule, but the program terms still define the cash-price unit as a 28-day fill. Our annual tables follow the program's pricing unit so the products can be compared consistently.

There is no bulk discount. We checked every row.

You'd assume buying three months at once saves money. It doesn't. Novo publishes the multi-month standard prices right in the terms, and they're exactly double and triple:

Zero discount. The intro rows show no two- or three-month option at the intro rate. You cannot turn a $199 injection intro fill or the $149 limited 4 mg tablet fill into a discounted 90-day order.

Buying a standard-price multi-month supply can still be worth it for convenience, and NovoCare says a 90-day supply is available when the prescriber writes it that way and the patient requests it. Just don't expect a price break.

---

5. Pill or pen — the $949 question

For an eligible new patient who gets both current intro offers, a first year of Wegovy tablets costs about $3,288 and the Wegovy pen about $4,237 — a $949 difference. A full maintenance year is also $949 apart: 12 tablet bottles at $299 cost $3,588, while 13 pen boxes at $349 cost $4,537. If you do not qualify for either intro offer, the first-year gap is $1,199.

We built this ledger because the monthly tables don't show the real first-year total. Here's exactly how.

How we calculated it: we took the FDA-label dose steps, applied Novo's published price to each fill, and counted fills the way the program terms price them. Injections are 28-day fills, which produces 13 boxes in a 364-day model. Tablets are 30-day bottles, which produces 12 bottles in 360 days. We assumed one fill at each starting step, no dose delays, no insurance, and prices verified August 15, 2026. Real treatment can pause or stay at a dose longer, so this is a price-path model, not a promise of what your doctor will prescribe or your exact calendar-year bill.

The first-year ledger

Four things jump out of that table.

One: across the first-year paths we modeled, the cost runs from $2,338 to $6,037. That's a $3,699 spread inside one pharmacy program. Same company. Same active ingredient. Different labels, forms, doses, and offer eligibility.

Two: the clean $949 headline is real, but it needs the right comparison. It is the gap when a new Wegovy tablet patient gets the limited 4 mg offer and a new Wegovy pen patient gets the two-fill intro. It is also the gap in a full maintenance year. If neither intro applies, the first-year gap is $1,199.

Three: mixed eligibility changes the first-year gap. If the pen intro applies but the 4 mg tablet offer does not, the pill is $899 less. If the tablet offer applies but the pen intro does not, it is $1,249 less. That's why a single yearly number without the eligibility rule can mislead you.

Four: the annual gap is not a hidden $200 monthly difference. At comparable standard doses, the pill is usually $50 less per priced fill: $299 versus $349. The annual total is also shaped by the units — 12 thirty-day tablet bottles versus 13 twenty-eight-day pen boxes.

What the money doesn't tell you

The pill is cheaper. It is not automatically easier.

The tablet has to be taken first thing in the morning, on an empty stomach, with no more than 4 ounces of plain water. Then you wait at least 30 minutes before eating, drinking anything else, or taking another oral medicine.

That's not a suggestion. It's how the drug gets absorbed. If your mornings are chaotic, or another medicine needs the same empty-stomach window, a once-a-week shot may genuinely fit your life better — and roughly $949 in a full maintenance year may be a fair price for not thinking about it six mornings out of seven.

We're not going to tell you the pill works better or worse than the shot. That's a clinical question and it belongs to your doctor. For the evidence side of that comparison, see Wegovy pill vs. injection.

---

6. The two doors — and why picking the wrong one costs you

The same headline prices appear under two separate programs with different terms. NovoCare Pharmacy is a cash-only home-delivery route. The retail savings offer is used at an eligible pharmacy and can work after commercial insurance is billed. Which door you use changes the definition of “new patient,” the deadline, whether insurance can be involved, and what can be combined with the offer.

This is the comparison we haven't seen laid out in one place, and it's worth five minutes.

There are two live rulebooks. Both are on Novo's site. Both show $199 injection intro prices and a $149 Wegovy tablet offer. They do not say the same thing.

Two things you can do with this today:

If you used the Wegovy injection savings offer more than 365 days ago, Door B may treat you as new again. That is not a blanket promise. You still have to meet every current eligibility rule, and the 365-day wording belongs to the Wegovy injection retail offer — not every NovoCare product.

Door A gives an eligible prescription a later shipping date. For the pharmacy offers, the prescription must be written and received by the listed cutoff, but shipment can happen through the following month. The retail terms use a filled-by deadline. That difference matters if the deadline is close.

That's not a loophole. It's what the current terms say.

And one more thing about the pen and pill

Door A treats the Wegovy injection and Wegovy tablets as separate products for its new-patient rules. Using an injection offer does not automatically mean you have filled the tablet product through NovoCare Pharmacy.

But don't turn that into a do-it-yourself switching plan. The FDA label gives a specific switch from Wegovy 2.4 mg injection to Wegovy 25 mg tablets. It does not say to jump from the injection to the 4 mg intro bottle. Your prescriber has to write the new product and follow the label.

→ Use the NovoCare Picker to find your lane, door, and deadline. It takes less than a minute and does not ask for an email.

---

7. What if I have insurance?

If you have eligible commercial insurance that covers Wegovy or Ozempic, the manufacturer savings offer can lower your cost to as little as $25 per fill, with up to $100 of savings on a one-month fill. That offer is used through an eligible retail pharmacy after the insurance claim — not through NovoCare Pharmacy's cash-only home-delivery route. Coverage, copay, plan design, product, and offer eligibility all matter.

Start here, because the two routes can look like one offer on Novo's pages.

NovoCare Pharmacy itself does not accept insurance. The $25 language belongs to the separate savings program, usually processed at a participating retail pharmacy. The terms also describe a mail-order reimbursement path in some cases, but it is still separate from NovoCare Pharmacy's cash home delivery. So if you have strong coverage and choose cash delivery because it looks simpler, you could pay hundreds for a fill your plan and the savings offer would reduce much further.

The $25 isn't always $25

Maximum savings is $100 per one-month fill, $200 for a two-month fill, and $300 for a three-month fill under the current terms. So the final amount depends on the copay before the savings is applied.

• If the covered one-month copay is $125, the offer can bring it to $25.
• If the copay is $200, the $100 cap leaves $100.
• If the copay is $400, the $100 cap leaves $300.

That is the opposite of the NovoCare cash side, where a standard three-month order is simply three times the one-month price.

Some plans disqualify you and don't tell you

The terms exclude patients whose plans use certain designs, including:

• Accumulator adjustment programs — the plan may not count manufacturer assistance toward the deductible or out-of-pocket limit
• Copay maximizer programs — the plan structures the copay around the available manufacturer assistance
• Alternate funding programs — the plan sends patients outside the normal benefit to seek manufacturer or other funding

If your plan uses one of these designs, the terms may make you ineligible for the offer. Call the number on the back of your insurance card and ask using those exact phrases.

FEHB, ACA marketplace, and state employee plans are not automatically excluded

The savings terms say the Federal Employees Health Benefits Program, Affordable Care Act exchange plans, and state employee insurance are not treated as federal or state government health programs for this rule. That removes one automatic exclusion. It does not guarantee that every person in one of those plans qualifies; the rest of the offer terms still apply.

The deductible catch depends on the door

The two routes do not have the same deductible story.

• NovoCare Pharmacy cash purchase: it does not run through insurance, and the terms say the patient will not submit it for insurance reimbursement. It ordinarily will not appear as a covered claim toward the deductible or out-of-pocket maximum.
• Retail insured savings offer: the pharmacy bills the commercial plan first, then applies eligible savings. Novo's terms say the manufacturer intends the savings to benefit the patient, but accumulator or maximizer designs can keep some or all of that assistance from counting.

If you usually hit your deductible, compare the whole-year effect — not just the number at the register.

*→ Check whether your plan covers the Wegovy pen before you pay cash (sponsored).* Ro's free checker covers the Ozempic pen, Wegovy pen, and Zepbound pen. It asks for your identity and insurance-card information so it can contact the plan; it is not an anonymous quote.

One honest limit: the checker does not currently cover the Wegovy pill, Ozempic pill, Foundayo, or Zepbound KwikPen. For either tablet, call the plan directly and ask about the exact product and NDC.

---

8. What if I have Medicare or Medicaid?

Eligible Medicare Part D beneficiaries can get certain weight-management GLP-1 products for a $50 copay per monthly fill through the Medicare GLP-1 Bridge, a CMS demonstration running from July 1, 2026 through December 31, 2027. Every current Wegovy formulation listed on this page — tablets, the standard pen, and Wegovy HD — is included. Ozempic is not. Prior authorization and the Bridge's clinical criteria apply.

If you're on Medicare, check this before you pay a NovoCare cash price.

Who can qualify for the $50 Medicare GLP-1 Bridge?

The prescription must be for reducing excess body weight and maintaining weight reduction with ongoing nutrition and physical-activity changes. The person must be an adult in an eligible Part D plan type and must have met one of these clinical paths when GLP-1 treatment began:

CMS says the starting BMI can be used when a person began GLP-1 treatment, even if weight has fallen by the time the prior authorization is submitted.

Eligible plan types include standalone Part D plans and listed Medicare Advantage plans with drug coverage. Some other plan types are excluded unless the person is also enrolled in a standalone Part D plan. The cleanest first check is your Part D or Medicare Advantage drug-plan status, then the clinical criteria.

How the Bridge actually starts

1. Your prescriber sends an eligible prescription to a pharmacy. A Part D denial is not required first.
2. The pharmacy sends a claim to the Medicare GLP-1 Bridge. CMS says the prescriber should not submit the prior authorization before that claim, because the system may return “patient not found.”
3. The pharmacy sends the prior-authorization request to the prescriber. CMS says this typically happens within 24–72 hours after the claim.
4. The prescriber submits the clinical information. CMS sends the approval or denial within 72 hours after submission.
5. After approval, the pharmacy resubmits the claim and collects the $50 copay.

Who should use normal Part D coverage instead?

The Bridge is for weight management. CMS says prescriptions for Part D-coverable indications — including type 2 diabetes, moderate-to-severe obstructive sleep apnea, and qualifying MASH — should go through the Part D plan instead. A prescription being used to reduce major cardiovascular events should also be routed to Part D, even when the patient also wants weight loss.

This is why the shortcut “your plan already covers any GLP-1, so you are out” is too broad. The deciding issue is the indication and CMS's eligibility process, not simply whether the plan has ever covered a GLP-1.

What the $50 does and doesn't do

The Part D deductible does not apply to a Bridge fill. But the $50 copay also does not count toward Part D true out-of-pocket spending, and the Low-Income Subsidy does not reduce it. Twelve monthly fills would be $600.

We could not verify that NovoCare Pharmacy's home-delivery workflow itself processes Bridge claims. NovoCare is cash-only, while the Bridge runs through a separate CMS claims processor. Until NovoCare or CMS publishes a clear answer, use a pharmacy that confirms it can route the claim to the Medicare GLP-1 Bridge before sending the prescription.

For beneficiary help, call 1-800-MEDICARE (1-800-633-4227). Prescribers with a Bridge prior-authorization question can call 855-273-0102, Monday through Friday, 8 a.m.–7 p.m. ET.

Medicaid: coverage varies by state, product, and indication. There is no national yes or no. The commercial savings offers generally exclude Medicaid because it is a government health program. NovoCare Pharmacy's cash terms may permit an eligible self-pay purchase, but it will not be billed to Medicaid or submitted for reimbursement. Ask the state plan whether paying cash affects any program rules before doing it.

No sponsored links in this section. If the Bridge or Part D is your best route, that's the answer and we're not going to route you past it.

---

9. How do you actually get one — and what if you don't have a doctor?

NovoCare Pharmacy is a pharmacy channel, not a clinic. It cannot evaluate you or write a prescription. A licensed prescriber has to send a valid prescription to NovoCare Pharmacy. For people without a prescriber, Novo Nordisk publishes a list of eight independent telehealth companies it says are recognized for legitimate medicine sourcing and patient support. Novo also says it does not endorse them.

This is where most people get stuck, and it's not a money problem.

The steps

1. Talk to a prescriber. They decide whether the medicine is appropriate, which product fits the FDA-approved use, and what dose to use.
2. Have the prescriber send the prescription to NovoCare Pharmacy. Use the exact routing card below if the pharmacy does not appear in the office's system.
3. Make sure the prescription includes your current mobile number and email. NovoCare asks prescribers for both so it can contact you.
4. Watch for pharmacy outreach. After the prescription is received and validated, you may hear from NovoCare, CoAssist, CenterWell, or an intake partner disclosed in the terms.
5. Set up the account and pay. NovoCare states that standard cards, Apple Pay, Google Pay, and HSA/FSA cards are accepted.
6. Schedule free delivery. Novo does not publish a guaranteed end-to-end delivery time, so leave room before the medicine is needed.

Send this to your prescriber

NovoCare Pharmacy
2400 Sand Lake Rd, Ste. 200B
Orlando, FL 32809
Phone: 1-833-949-5527
Fax: 1-833-947-0246
NPI: 1710671854
NCPDP: 5758074 Please include the patient's current mobile number and email address with the prescription.

Novo publishes these details specifically for prescribers whose software can't find the pharmacy. If your doctor's office says, “I don't see it in my system,” this card is the fix. Print it or screenshot it before the appointment.

If you don't have a prescriber

Then no price on this page matters yet, because you can't buy any of it.

Novo Nordisk maintains a list of eight independent telehealth companies it describes as recognized for legitimate medicine sourcing and patient support. Here's the capability grid Novo showed when we verified the page:

Read Novo's own limit before you read ours: it says the companies operate independently, Novo does not endorse them, and Novo does not pay or receive referral compensation for putting them on that list.

Being on the list supports the sourcing-and-support claim Novo chose to publish. It does not mean Novo vouches for every clinician, every care decision, every price, or availability in every state.

Here's the part we'd rather you hear from us

Ro is not the cheapest way to buy these medicines, and we're not going to pretend otherwise.

If you already have a prescriber who can handle the evaluation and follow-up, send the prescription straight to NovoCare and avoid a separate telehealth membership. Your existing clinician may still charge for care, but NovoCare itself does not add a care-membership fee.

Ro's Body membership is $39 for the first month, then $149 month to month. The listed prepaid choices work out to $99 a month for three months, $89 a month for six months, or $74 a month for a year paid upfront. Medicine is separate. Over a year, that is real money, and if you don't need the service, don't spend it.

If that's you — you have a willing prescriber — skip the membership. Go direct. Use the card above. That's the honest recommendation, and we don't earn a cent from it.

But most people reading this don't have a prescriber lined up. That's the actual wall. NovoCare can't get you over it, because a pharmacy cannot perform the clinical evaluation and prescribe.

Ro is one of the companies on Novo's published list, offers ongoing clinical care, and has a free insurance-coverage check before a paid membership is needed. The exact pharmacy and medicine path still depend on the prescription, coverage, availability, and what you choose; being on Novo's list is not a promise that every Ro prescription is filled by NovoCare Pharmacy.

*→ See whether Ro's program fits you (sponsored). The first month is $39; ongoing plans range from $74 a month prepaid annually to $149 month to month. Medicine is billed separately. If you already have a prescriber, use the card above instead — it should cost you less in added care fees.*

If you'd rather pick your own doctor

Ro matches you with a clinician. Some people would rather choose.

Sesame lets you browse participating providers and book through its weight-loss program. It is also on Novo's published list. Sesame advertises its program from $59 a month when billed annually or $99 month to month, with medicine separate; individual providers may have different prices or services.

*→ Browse Sesame clinicians and current visit pricing (sponsored).* You can review the participating provider before booking.

And to be complete: the other six on Novo's list — 9amHealth, eMed, Form Health, knownwell, LifeMD, and WeightWatchers — may also be worth comparing. We don't have paid relationships with them on this page. Check the provider's current state availability, total care cost, labs, follow-up, cancellation rules, and medicine-routing process before paying.

---

10. Why is a pharmacy I've never heard of texting me?

A NovoCare Pharmacy order can involve three disclosed companies. AssistRx supports intake and outreach. CoAssist Pharmacy does business as NovoCare Pharmacy and receives prescriptions. An eligible prescription may then be transferred to CenterWell Pharmacy for validation, account setup, payment, refills, and shipping. Seeing one of those names after your prescriber sends the prescription does not automatically mean something went wrong.

You sent a prescription to “NovoCare.” Now you're getting a message from CenterWell. Did something go wrong?

Probably not. Here's the chain described in the current terms:

The word may matters. The terms allow the CoAssist-to-CenterWell transfer; they do not promise that every order will produce an identical sequence of messages from all three companies.

How to tell a real message from a scam: a legitimate message should follow a prescription you actually asked a clinician to send. Do not trust a link only because the message uses a real company name. If the timing is wrong, the sender asks for unusual payment, or anything looks off, do not click. Call NovoCare Pharmacy at 1-888-809-3942 using the number from the official site.

If no text arrives

---

11. What ordering is actually like

NovoCare Pharmacy states that shipping is free, standard cards and HSA/FSA cards are accepted along with Apple Pay and Google Pay, and a standard-price 90-day supply can be sent when the prescriber writes it that way and the patient requests it. Novo does not publish a guaranteed delivery timeframe.

The practical stuff, since it's scattered across several pages:

• Shipping is free. No NovoCare membership fee or delivery minimum is listed.
• HSA and FSA cards are accepted. Save the receipt. The account administrator decides whether the expense is eligible under your plan.
• Standard 90-day supplies are available when the prescription is written for that amount and you request it. Remember from Section 4: there is no bulk price break, and limited intro prices are not offered as multi-month orders.
• A retail-pharmacy route exists. That is the separate door for insured claims and retail savings offers. It is not the same transaction as NovoCare's cash home delivery.
• Refill communication may come by text or phone. Keep your contact information current.

On timing, we're going to be careful. Novo says processing can take time but does not promise a full prescription-to-door date. We're not going to invent one, and we'd be suspicious of any page that does. Request the refill with room to spare and follow the pharmacy's instructions.

What patients say about the service

Novo publishes patient comments about ordering on its own site. Two short examples say that refills and delivery were hassle-free and that ordering felt simple and straightforward.

These comments are selected and published by NovoCare from patients using CoAssist Pharmacy d/b/a NovoCare Pharmacy. They're about ordering and delivery — not how well the medicine works, and not a promise your experience will match. We looked for a large, independent, verified review body focused on this exact ordering channel and did not find one we would use for an honest average. So we're not going to dress up something thin as social proof.

---

12. The honest downsides

NovoCare Pharmacy's strengths and limits come from the same thing: it's a fulfillment channel, not a clinical care program. It has pharmacy support, but no medical evaluation, no dose-management visits, no coaching, and no prescribing clinician who can change the treatment plan. It accepts cash only, cash fills do not run through insurance, intro prices expire, and Novo Nordisk can change or end the offers.

Everything on this list is real. None of it is hidden in our fine print.

It won't take care of you medically. No evaluation, no treatment plan, no dose decision, no clinical check-in, and no prescribing clinician to assess symptoms or change treatment. If you need that, you need an in-person clinician or telehealth program on top of the pharmacy. → Section 9

Cash only, outside your insurance claim. NovoCare does not accept insurance, and its terms say not to submit the cash purchase for reimbursement. That means the fill ordinarily will not count like a covered pharmacy claim toward your deductible or out-of-pocket maximum. → Compare the insurance route in Section 7

The headline price is not your whole-year price. $199 is two eligible injection fills. Then the standard Wegovy pen price is $349. The Wegovy tablet starts at $149, but the standard second dose is $199 and the next two are $299. Anyone quoting one starting number as the yearly cost has not shown you the price path.

Prices and offers can change. Novo sets the program terms and reserves the right to change or end them. The August 31 and December 31 deadlines on this page are not evergreen promises.

One molecule only. Semaglutide. If it does not agree with you and your doctor wants tirzepatide or another treatment, you're leaving this pharmacy program.

Enrollment can pause. Novo's terms reserve the right to pause or end enrollment, including to protect supply for patients already participating.

More handoffs can occur than at a one-counter pharmacy. AssistRx, CoAssist, and CenterWell can each have a role. That can make a real message look unfamiliar and creates more places where a missing email, phone number, or transfer can slow the process.

---

13. Is NovoCare Pharmacy legitimate?

Yes. NovoCare Pharmacy is Novo Nordisk's branded cash-pharmacy program for its own FDA-approved Wegovy and Ozempic products. The published terms identify CoAssist Pharmacy d/b/a NovoCare Pharmacy and CenterWell Pharmacy as licensed dispensing partners in the process. The medicine should arrive as the FDA-approved Novo Nordisk product with the package NDC tied to the prescription — not as a compounded substitute.

The channel is real. The clinical care is somewhere else.

What it is not: a telehealth clinic, a discount card, a medical subscription, or a compounding pharmacy. A licensed prescriber must decide on treatment, and the pharmacy fills the prescription.

The legitimacy chain we verified

A word on compounded medicines, since they'll show up in your search results. Compounded semaglutide is made by a compounding pharmacy, not by Novo Nordisk. A compounded drug is not FDA-approved as a finished product and is not the same product as Wegovy or Ozempic. Federal law can allow compounding in specific circumstances, including when a prescriber identifies a patient need that an approved product cannot meet and the applicable requirements are satisfied. That is a different treatment path with a different regulatory status. We don't blur the two, and this page is only about the FDA-approved brand-name channel.

One practical verification step: when the package arrives, check the product name, strength, dosage form, lot and expiration information, tamper evidence, and NDC before the first dose. If anything does not match the prescription or looks damaged, call the dispensing pharmacy before using it.

---

14. Safety: what to know before you take any of these

Every NovoCare product on this page contains semaglutide and carries a boxed warning about thyroid C-cell tumors. Do not use it if you or a family member has had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious allergic reaction to semaglutide or a product ingredient. Nausea, diarrhea, vomiting, constipation, and stomach pain are among the common side effects, but the exact label and warnings differ by product and form.

Price should never be the reason you pick a medicine. Here's what actually matters, in plain terms.

The boxed warning — the FDA's strongest warning. Semaglutide caused thyroid C-cell tumors in rodents. It is not known whether it causes these tumors in people. Tell your clinician if you notice a neck lump or swelling, hoarseness, trouble swallowing, or shortness of breath.

Don't take it if:

• You or a family member has had medullary thyroid carcinoma, a specific thyroid cancer
• You have MEN 2, an inherited endocrine condition
• You have had a serious allergic reaction to semaglutide or an ingredient in the product

Tell your clinician before treatment if you: have had pancreas or kidney problems, have diabetic eye disease, have severe stomach-emptying problems, have surgery or deep sedation coming up, are pregnant or planning pregnancy, are breastfeeding, or take insulin or a sulfonylurea.

For weight treatment, the Wegovy label says to stop semaglutide when pregnancy is recognized. The Wegovy and Ozempic labels also say to stop at least two months before a planned pregnancy because semaglutide remains in the body for a long time. Your clinician has to apply the exact label to your reason for treatment.

Serious things to watch for: severe and lasting stomach pain, gallbladder symptoms, dehydration from vomiting or diarrhea, low blood sugar when used with certain diabetes medicines, allergic reactions, sudden vision changes, and symptoms of a severe stomach-emptying problem. The Wegovy label also carries warnings about increased heart rate and aspiration risk during anesthesia or deep sedation. Read the exact product label, because not every warning is written the same way for every form.

One current-label correction: the June 2026 Wegovy prescribing information says the suicidal-behavior-and-ideation warning was removed in January 2026. We do not list it as a current Wegovy warning.

One difference between the pill and the shot that's easy to miss: breastfeeding is not recommended while taking Wegovy Tablets or Ozempic Tablets. For the injections, the labels say human-milk data are not available and tell the patient and clinician to weigh the benefits and risks. Same active ingredient, different formulation guidance.

Don't combine products on your own. Wegovy should not be used with another semaglutide-containing product or another GLP-1 receptor agonist. Do not add a second semaglutide product to Ozempic on your own. A switch between products needs clear instructions from the prescriber. Never use two prescriptions just because both contain the same ingredient.

Full FDA-approved prescribing information:

• Wegovy injection and tablets
• Ozempic Tablets
• Ozempic injection

Read the Medication Guide that comes with your exact product. Call the prescriber or pharmacist when anything on this page conflicts with the package in your hand.

---

15. How we compared these treatment paths

The RX Index scores providers and treatment paths on five pillars, in this order: clinical legitimacy, care quality, transparency, access, and cost. Commercial relationships do not change what the evidence shows. Every price and program fact on this page traces to a dated primary source, and every annual total shows the assumptions behind our calculation.

Clinical legitimacy. NovoCare is the manufacturer-branded channel for FDA-approved Novo Nordisk medicine, requires a valid prescription from a licensed prescriber, and limits participation to an approved use on the product's label. That's about as clean as a medicine-sourcing chain gets.

Care quality. This is NovoCare's weak pillar and we'll say it plainly: there is no clinical care in the pharmacy price. There is pharmacy and process support, but no evaluation, dose management, or treatment follow-up. That job stays with your clinician — or with a telehealth service you pay separately.

Transparency. Strong on published dose prices, weaker on how the offers fit together. The terms disclose the prices and deadlines, but the pharmacy route, retail savings offers, product labels, and Medicare Bridge live in separate documents. That's exactly why the two-door problem in Section 6 exists.

Access. Free home delivery, an eligible retail-pharmacy route, an exact prescriber-routing card, and a Medicare pathway. The hard limit is the prescription and, for each discount route, its eligibility rules.

Cost. The direct cash prices are published by dose, and there is no separate NovoCare care membership. But “lowest” depends on insurance, manufacturer savings, Medicare eligibility, dose, form, and whether you already have a prescriber. We show each lane instead of declaring one number the universal winner.

Why there's no RX Index Score next to NovoCare on this page. We're not publishing a precise-looking number until the same finalized weighting has been applied to every manufacturer-direct and telehealth path. A number without a stable method is decoration, not evidence.

---

What we actually verified

Verified August 15, 2026, against primary sources:

• Four product lanes and 16 package-and-strength entries — NovoCare Pharmacy Terms and Conditions
• Every NovoCare self-pay price by dose and the one-, two-, and three-month standard-price rows — same source
• The limited 4 mg Wegovy tablet rule, August 31 prescription cutoff, and September 30 shipping cutoff — same source
• The Wegovy injection intro rule, December 31 prescription cutoff, and January 31, 2027 shipping cutoff — same source
• Cash-only status, labeled-use eligibility, and the no-insurance-reimbursement attestation — same source
• The AssistRx, CoAssist, and CenterWell roles — same source and NovoCare's pharmacy pages
• The exact pharmacy address, phone, fax, NPI, NCPDP, free shipping, and 90-day option — NovoCare's health-professional pharmacy page
• The 365-day Wegovy injection retail-offer definition and accumulator, maximizer, alternate-funding, FEHB, ACA, and state-employee language — current manufacturer savings terms
• The eight telehealth companies and Novo's capability grid and non-endorsement disclosure — NovoCare Find a Doctor page
• Each form's FDA-approved indications, dose schedule, form-specific maintenance doses, switching rule, boxed warning, pregnancy language, lactation language, the January 2026 removal of the suicidal-behavior warning, and package NDCs — current FDA-approved prescribing information
• Medicare GLP-1 Bridge dates, products, clinical criteria, claim-first workflow, $50 copay, and Part D accounting — CMS
• Ro's current plan prices and insurance-checker scope — Ro's official pricing and checker pages
• Sesame's advertised $59 annual-plan equivalent and $99 month-to-month starting price — Sesame's official program page
• The FDA status and limited role of compounded drugs — FDA compounding questions and answers

Original evidence assembled on this page:

• First-year and maintenance ledgers using 12 thirty-day tablet bottles versus 13 twenty-eight-day injection boxes
• All four Wegovy pill-versus-pen first-year eligibility combinations: $899, $949, $1,199, or $1,249 apart
• A standard-price and intro-price annual range across every NovoCare path shown here
• A side-by-side comparison of the cash home-delivery rulebook and the retail savings rulebook
• The provider-stated-versus-verified table and the form-specific indication matrix
• The official-label NDC conflict for the Ozempic 4 mg, 30-tablet bottle

What we could not verify, and therefore did not claim:

• Any guaranteed prescription-to-door delivery time
• That NovoCare Pharmacy home delivery itself processes Medicare GLP-1 Bridge claims
• A numerical customer-satisfaction score based on a large independent review set
• State-by-state telehealth availability for every provider in Section 9
• That every order follows the exact same AssistRx-to-CoAssist-to-CenterWell sequence

Every price on this page carries an August 15, 2026 verification date. If you're reading this later, check the current NovoCare Pharmacy terms before planning around a number.

---

Frequently asked questions

Does NovoCare Pharmacy sell Ozempic? Yes. It lists Ozempic Tablets and Ozempic injection at all current doses shown in its terms. It is not a Wegovy-only pharmacy channel.

Can I get Ozempic for weight loss through NovoCare? No. NovoCare requires an FDA-approved use on that exact product's label, and weight loss is not an Ozempic indication. For weight treatment, the NovoCare products are Wegovy tablets and Wegovy injection.

Is NovoCare Pharmacy a telehealth company? No. It's a pharmacy channel. It fills prescriptions and ships medicine. A separate licensed prescriber has to evaluate you, choose treatment, and write the prescription.

Do I need Ro to use NovoCare Pharmacy? No. Any qualified prescriber who is willing to manage your care can send the prescription directly. Ro and similar services are for people who need a prescriber or want ongoing telehealth support.

How long does the $199 Wegovy pen price last? Two eligible 28-day fills: one at 0.25 mg and one at 0.5 mg. The next Wegovy pen fill is $349 under the current standard price.

Is the 4 mg Wegovy pill always $149? No. The standard NovoCare price is $199. An eligible new tablet patient can get one 4 mg fill for $149 if the prescription is written and received by August 31, 2026 and the bottle ships by September 30, 2026.

Does NovoCare Pharmacy take insurance? No. It's cash/self-pay. The commercial-insurance savings route is a separate program used at an eligible retail pharmacy.

Can I use GoodRx or a copay card with NovoCare Pharmacy? Not with the NovoCare Pharmacy cash offer. Its terms prohibit combining that offer with another coupon, discount, or savings card. The retail savings program has separate rules.

Does NovoCare accept HSA or FSA cards? NovoCare says yes. Standard cards, Apple Pay, and Google Pay are also listed. Keep the receipt; your account administrator decides whether the purchase is eligible.

Is shipping free? NovoCare states that home shipping is free. No separate delivery membership is listed.

Can I get a 90-day supply? NovoCare says yes when the prescriber writes it that way and you request it. Standard prices are simply multiplied by the number of months, and intro offers are not sold as discounted multi-month fills.

Why did I get a text from CenterWell? CenterWell is a disclosed fulfillment pharmacy in the NovoCare process. A prescription may be transferred there for validation, payment, refills, and shipping. Verify unexpected messages by calling the official NovoCare number instead of clicking a link.

My doctor can't find NovoCare in the system. What do I do? Give the office the address, phone, fax, NPI, and NCPDP number from the routing card in Section 9.

Is there a discount for buying three months at once? No. The published standard-price tables show two- and three-month amounts at exactly two and three times the one-month price.

Can I switch from the pen to the pill later? Only through your prescriber. The Wegovy label includes a specific switch from 2.4 mg injection to 25 mg tablets. It does not tell patients to switch themselves or to use the 4 mg intro bottle after an injection.

Can Medicare patients get Wegovy for $50? Some can. The Medicare GLP-1 Bridge covers all current Wegovy formulations for eligible Part D beneficiaries using them for weight management who meet CMS's plan and clinical criteria. The program runs through December 31, 2027.

Can the Medicare Bridge be filled through NovoCare home delivery? We did not find a primary source that confirms it. Use a pharmacy that says it can submit the Bridge claim, and verify before the prescription is sent.

Does NovoCare sell Zepbound or Mounjaro? No. Those are Eli Lilly tirzepatide products. See our LillyDirect guide.

What's the difference between NovoCare and NovoCare Pharmacy? NovoCare is Novo Nordisk's broader patient-support platform. NovoCare Pharmacy is the cash home-delivery pharmacy program for the Wegovy and Ozempic products listed in its terms.

Is NovoCare available in my state? NovoCare describes nationwide home delivery and identifies CoAssist as licensed across the United States and territories. A specific product, pharmacy role, or offer can still depend on current law, licensing, supply, and program eligibility, so confirm when the prescription is sent.

---

Still not sure which GLP-1 program is right for you?

Take our free two-minute matching quiz.

You'll get a personalized shortlist based on your state, insurance, pill-or-injection preference, support needs, and budget — with source-verified pricing on every option we show you.

---

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Primary sources, all accessed and verified August 15, 2026:

• NovoCare Pharmacy Terms and Conditions
• NovoCare Pharmacy information for prescribers
• NovoCare Find a Doctor
• Wegovy Savings Offer terms
• Ozempic and diabetes-product savings terms
• Wegovy FDA-approved prescribing information
• Ozempic Tablets FDA-approved prescribing information
• Ozempic injection FDA-approved prescribing information
• CMS Medicare GLP-1 Bridge
• CMS Medicare GLP-1 Bridge information for providers
• FDA: Compounding and the FDA — Questions and Answers
• Ro weight-loss program pricing
• Ro GLP-1 Insurance Coverage Checker
• Sesame weight-loss program

This page is for general information. It isn't medical advice and it isn't a substitute for talking with a licensed clinician about your own health.